The 18th meeting of the Member State Coordination Group on Health Technology Assessment established by Regulation (EU) 2021/2282 was held on 12 February 2026 in Brussels. Representatives from all Member States joined the meeting, as...
The document provides answers to questions asked by stakeholders on the Joint Clinical Assessment (JCA) process. Read the background document published by DG Health and Food Safety on 18 May 2026.
The purpose of this document is to provide general principles to be used when assessing the requests for confidentiality from health technology developers in the context of joint clinical assessments. The specific circumstances in relation...
In this webinar, Chairs and Co-chairs of the Member State Coordination Group on Health Technology Assessment (HTACG) and its subgroups explained the process for joint clinical assessments and joint scientific consultations. The webinar also covered...
On 1 April, the Commission will open the second request period for joint scientific consultations (JSCs) for 2026. JSCs enable health technology developers to consult on the planning of their health technology and how clinical...
The document provides the first annual report covering the main activities of the Coordination group and its subgroups in 2025. Read the minutes published by DG Health and Food Safety on 16 February 2026.
The 18th meeting of the Member State Coordination Group on Health Technology Assessment (HTACG) set up by Regulation (EU) 2021/2282 was held on 12 February 2026 in Brussels. The HTACG agreed on the strategic importance...
The Industry Standing Group (ISG) is a forum for interaction that has been established as part of the EMA’s continuous improvement for engagement with industry stakeholders supply chain of human, veterinary and medical device sectors...
The Commission has opened the first submission period for joint scientific consultations (JSCs) for 2026. JSCs enable health technology developers (pharma and medtech companies) to consult with the Health Technology Assessment agencies in the Member...
This report fulfils the obligation to publish anonymised, aggregated, non confidential information as referred to in article 30(3) (m) of the EU HTA Regulation. It also promotes transparency and public awareness of the EU HTA...
